Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Zhenzhong Qian"'
Autor:
Ying Ding, Nannan Chu, Linling Que, Kai Huang, Yuanxing Chen, Wei Qin, Zhenzhong Qian, Yunfei Shi, Zhen Xu, Qing He
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Externí odkaz:
https://doaj.org/article/ef9b56e1f6164aa2b58e84d08d94d9fd
Autor:
Ying Ding, Nannan Chu, Linling Que, Kai Huang, Yuanxing Chen, Wei Qin, Zhenzhong Qian, Yunfei Shi, Zhen Xu, Qing He
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Objective: The main purpose of this study was to evaluate the pharmacokinetics, bioequivalence, and safety properties between a new generic and a brand reference formulation of esomeprazole enteric-coated tablets 20 mg in healthy Chinese subjects und
Externí odkaz:
https://doaj.org/article/24c0d4cd04334bc8ade86943b688acd1
Autor:
Linling Que, Wei Qin, Yunfei Shi, Ying Ding, Kai Huang, Zhenzhong Qian, Bingjie Huang, Peipei Zhou, Qing He
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Background and Objectives: Janumet® XR is the combination of sitagliptin and extended metformin hydrochloride produced by Merck Sharp & Dohme. It is specially designed for diabetes mellitus patients taking both drugs already. Janumet® XR exhibited
Externí odkaz:
https://doaj.org/article/0de94f5e4332422f935f1033fabefab0
Autor:
Kai Huang, Yunfei Shi, Nannan Chu, Linling Que, Ying Ding, Zhenzhong Qian, Wei Qin, Xianghong Gu, Jiakun Wang, Zhiwei Zhang, Jianguo Xu, Qing He
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Objective: This study was performed to investigate the effect of food on the pharmacokinetics (PK) of WXFL10203614 in healthy Chinese subjects.Methods: This was a randomized, open-label, single-dose, two-treatment (fed vs fasted), two-period, two-seq
Externí odkaz:
https://doaj.org/article/3afd5acbae14491a926baa7f5a396b76
Autor:
Kai Huang, Ying Ding, Linling Que, Nannan Chu, Yunfei Shi, Zhenzhong Qian, Wei Qin, Yuanxin Chen, Xianghong Gu, Jiakun Wang, Zhiwei Zhang, Jianguo Xu, Qing He
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Objective: This study was conducted to investigate the safety, tolerability and pharmacokinetics (PK) of WXFL10203614 after single and multiple oral doses in healthy Chinese subjects.Methods: A single-center, randomized, double-blind, placebo-control
Externí odkaz:
https://doaj.org/article/ebbde913409e4571b21f893d9ed63197
Autor:
Kai Huang, Linling Que, Ying Ding, Nannan Chu, Zhenzhong Qian, Yunfei Shi, Wei Qin, Zhenni Li, Yuanxin Chen, Xianghong Gu, Jiakun Wang, Lin Zhang, Jisheng Zhang, Xiangyang Zhu, Yongmin Yang, Yuan Tang, Qing He
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Objective: This study was conducted to compare the pharmacokinetics, safety and immunogenicity of HOT-1010 with bevacizumab (Avastin®) in Chinese healthy male subjects.Methods: A single-center, randomized, double-blind, single-dose, parallel trial w
Externí odkaz:
https://doaj.org/article/32b04462331c4005ae0a3ed670018440
Autor:
Nannan Chu, Ying Ding, Linling Que, Kai Huang, Yuanxing Chen, Wei Qin, Zhenzhong Qian, Yunfei Shi, Zhen Xu, Qing He
Publikováno v:
Frontiers in Pharmacology. 14
Objective: The main purpose of this study was to evaluate the pharmacokinetics, bioequivalence, and safety properties between a new generic and a brand reference formulation of esomeprazole enteric-coated tablets 20 mg in healthy Chinese subjects und
Autor:
Linling Que, Zhenzhong Qian, Xuemei Xiang, Ying Ding, Kai Huang, Yichuan Bai, Huanan Zhao, Qing He
Background and Objective Acarbose is a widely used α-glucosidase inhibitor to control postprandial hyperglycemia in type 2 diabetes mellitus patients. Recently, quite a few pilot studies on acarbose bioequivalence (BE) in Asian populations have defi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::51b42e742244d6c6cfddde20ddb29ad4
https://doi.org/10.22541/au.168080953.31882255/v1
https://doi.org/10.22541/au.168080953.31882255/v1
Autor:
Kai, Huang, Nannan, Chu, Ying, Ding, Linglin, Que, Zhenzhong, Qian, Yunfei, Shi, Wei, Qin, Qing, He
Publikováno v:
Clinical Pharmacology in Drug Development. 11:1116-1123
This study aimed to compare the pharmacokinetics, safety, and immunogenicity of the prefilled syringe (PFS) with lyophilized (LYO) recombinant human tumor necrosis factor-α receptor II:lgG Fc fusion protein (rhTNFR:Fc) in healthy Chinese male subjec
Autor:
Ying Ding, Nannan Chu, Linling Que, Kai Huang, Yuanxing Chen, Wei Qin, Zhenzhong Qian, Yunfei Shi, Zhen Xu, Qing He
Publikováno v:
Frontiers in Pharmacology; 2023, p1-9, 9p